RESI Conference (Redefining Early-Stage Investments)

by | Sep 27, 2022 | News & Media

September 21-22, 2022

Biolexis Therapeutics Business Development Director Kyle Medley participated in RESI Conference (Redefining Early-Stage Investments), Boston, MA on Sep 21-22, 2022.

https://resiconference.com/

2023 Annual San Antonio Drug Discovery Symposium 

April 10-11, 2023 Biolexis Therapeutics CSO invited to present company MolecuLern™ technology at 2023 Annual San Antonio Drug Discovery Symposium held at Greehey Children’s Cancer Research Institute of University of Texas Health San Antonio....

AACR (American Association of Cancer Research) Annual Meeting

April 8-13, 2023 Biolexis management participated and presented pre-clinical data on CDK9 inhibitor at the AACR (American Association of Cancer Research) Annual Meeting on April 8-13, 2022, Ernest N. Morial Convention Center New Orleans, Louisiana. B137 / 13 -...